News | October 08, 2014

Cardinal Health Hosts Physician Panel on Balance of Clinical Excellence and Cost Effectiveness in Interventional Cardiology at TCT

October 8, 2014 — At the recent Transcatheter Cardiovascular Therapeutics (TCT) meeting, representatives from Cardinal Health and physicians from leading healthcare institutions led discussions to help interventionalists explore the balance between innovative approaches to lowering healthcare costs and maintaining high-quality patient care.

On Tuesday, Sept. 16, Cardinal Health Medical Segment CEO Don Casey discussed healthcare industry business model innovation before joining co-chair Martin B. Leon, M.D., from New York-Presbyterian Hospital/Columbia University Medical Center and panelists Michael Jaff, DO, from Massachusetts General Hospital; David Cohen, M.D., from Saint Luke’s Mid America Heart Institute; and Mark Burket, M.D., University of Toledo Medical Center for a panel entitled, “The Balance of Clinical Excellence and Cost-Effectiveness in Interventional Cardiology: Today and Tomorrow.”

“The healthcare system today, more than ever, needs new, innovative solutions that will allow providers to deliver great patient care while being fiscally prudent,” said Casey. “We believe there is an opportunity to build new solutions that combine product, services and analytics to bring more value to our customers.”

On the TCT show floor, Cardinal Health presented its interventional solution sets that help optimize interventional healthcare, including:

  • Operational efficiency — ensuring the right product in the right place at the right time from point of order to point of care;
  • Product quality — offering high-quality, cost-effective products from basic essentials to complex procedures to promote excellent patient care; and
  • Smart analytics — transforming data into actionable clinical, operational and financial insights.


For more information: www.cardinalhealth.com/interventional


Related Content

News | Cath Lab

December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...

Home December 20, 2023
Home
News | Cath Lab

October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...

Home October 26, 2023
Home
News | Cath Lab

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

Home October 25, 2023
Home
News | Cath Lab

October 20, 2023 — Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...

Home October 20, 2023
Home
News | Cath Lab

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
News | Cath Lab

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
News | Cath Lab

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
News | Cath Lab

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
News | Cath Lab

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

Home July 13, 2023
Home
News | Cath Lab

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

Home June 21, 2023
Home
Subscribe Now